Eye on Innovation
depression
- Study Finds AI Chatbot Can Improve Mental Health
- First Therapy Chatbot Trial Yields Mental Health Benefits
- AI Therapist Matches Human Care in Groundbreaking Mental Health Trial
- AI Therapy Chatbot Shows Promising Results in Landmark Mental Health Clinical Trial
- User-Centered Design of a Gamified Mental Health App for Adolescents in Sub-Saharan Africa: Multicycle Usability Testing Study.
- Your Phone Can Tell when You’re Depressed
- Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of Rejoyn™, the First Prescription Digital Therapeutic Authorized for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms
- Trustees Discuss Strategic Plans, Act on Budgets
- AI That Knows how Depression Looks